Key points are not available for this paper at this time.
Acinetobacter baumannii has emerged as a highly troublesome pathogen for many institutions globally. As a consequence of its immense ability to acquire or upregulate antibiotic drug resistance determinants, it has justifiably been propelled to the forefront of scientific attention. Apart from its predilection for the seriously ill within intensive care units, A. baumannii has more recently caused a range of infectious syndromes in military personnel injured in the Iraq and Afghanistan conflicts. This review details the significant advances that have been made in our understanding of this remarkable organism over the last 10 years, including current taxonomy and species identification, issues with susceptibility testing, mechanisms of antibiotic resistance, global epidemiology, clinical impact of infection, host-pathogen interactions, and infection control and therapeutic considerations.
Building similarity graph...
Analyzing shared references across papers
Loading...
Anton Y. Peleg
Discovery Institute
Harald Seifert
Universitat de Miguel Hernández d'Elx
David L. Paterson
Università Cattolica del Sacro Cuore
Clinical Microbiology Reviews
Harvard University
University of Pittsburgh
The University of Queensland
Building similarity graph...
Analyzing shared references across papers
Loading...
Peleg et al. (Tue,) studied this question.
synapsesocial.com/papers/69d8335cf4e559c61eae2cb2 — DOI: https://doi.org/10.1128/cmr.00058-07
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: